Order Entry
Austria
ContactUsLinkComponent
Human recombinant VEGF R3 (from HEK293)
Lieferant:  ACRO Biosystems
Zertifikate
Human recombinant VEGF R3 (from HEK293)
Lieferant:  ACRO Biosystems

Spezifikationen

  • Konjugation:
    Unconjugated
  • Protein/Peptid-Typ:
    Rekombinant
  • Ursprung:
    HEK293 cells
  • Spezies:
    Human
  • Lagerbedingungen:
    –20 °C
  • Endotoxingehalt:
    Less than 1,0 EU per μg by the LAL method.
  • Biologische Aktivität:
    Lyopilised from 0,22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human VEGF-C, His Tag at 5μg/ml (100 µl/well) can bind Human VEGF R3, Fc Tag with a linear range of 0,6-10 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilised Human VEGF R3, Fc Tag at 5μg/ml (100 µl/well) can bind Human VEGF-D, His Tag with a linear range of 0,08-0,6 μg/ml (Routinely tested).
  • Gen-ID:
    P35916
  • Frei von Trägern:
    Y
  • Frei von Proteasen:
    Y
  • Tierfrei:
    Y
  • Proteinsynonym:
    Flt-4|VEGFR3|FLT4|LMPH1A|VEGFR-3|PCLFLT41|FLT-41|FLT41|FLT-4|PCL
  • Protein/Peptid-Name:
    VEGF R3
  • Purity:
    >95%
  • Molecular weight:
    111,2 kDa
  • Endotoxinspiegel:
    Low
  • Zusammensetzung:
    Lyopilised from 0,22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
  • Frei von Nukleasen:
    Y
  • Transporttemperatur:
    Powder,RT

Spezifikationen

Frequently Bought Together